Gene · 10399
Papers3,110
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 3,110
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Disruption of Epithelial Barrier Integrity via Altered GILZ/c-Rel/RACK1 Signaling in Inflammatory Bowel Disease. | J Crohns Colitis | 2025 | 39693354 | PubTator, text mining | PubMed |
| iTRAQ-Based Proteomic Analysis of Spontaneous Achilles Tendon Rupture. | J Proteome Res | 2025 | 39601082 | PubTator, text mining | PubMed |
| VRK2 inhibits the replication of infectious bursal disease virus by phosphorylating RACK1 and suppressing apoptosis. | Int J Biol Macromol | 2025 | 39579830 | PubTator, text mining | PubMed |
| eIF3d specialized translation requires a RACK1-driven eIF3d binding to 43S PIC in proliferating SH-SY5Y neuroblastoma cells. | Cell Signal | 2025 | 39477045 | PubTator, text mining | PubMed |
| Combined spatially resolved metabolomics and spatial transcriptomics reveal the mechanism of RACK1-mediated fatty acid synthesis. | Mol Oncol | 2025 | 39425259 | PubTator, text mining | PubMed |
| The Use of a Novel Container for Secured Transport and Storage of Biological Material for Quantitative Human RNA Analysis. | Int J Mol Sci | 2024 | 39796092 | PubTator, text mining | PubMed |
| Correction: Exosomal PSM-E inhibits macrophage M2 polarization to suppress prostate cancer metastasis through the RACK1 signaling axis. | Biomark Res | 2024 | 39695864 | PubTator, text mining | PubMed |
| Insights into the regulation of mRNA translation by scaffolding proteins. | Biochem Soc Trans | 2024 | 39641595 | PubTator, text mining | PubMed |
| Coronavirus nucleocapsid protein enhances the binding of p-PKCα to RACK1: Implications for inhibition of nucleocytoplasmic trafficking and suppression of the innate immune response. | PLoS Pathog | 2024 | 39602452 | PubTator, text mining | PubMed |
| Exosomal PSM-E inhibits macrophage M2 polarization to suppress prostate cancer metastasis through the RACK1 signaling axis. | Biomark Res | 2024 | 39538297 | PubTator, text mining | PubMed |
| Multi-omics analysis revealed significant metabolic changes in brain cancer cells treated with paclitaxel and/or topotecan. | Heliyon | 2024 | 39524752 | PubTator, text mining | PubMed |
Retraction notice to "Preconditioning with endoplasmic reticulum stress alleviated heart ischemia/reperfusion injury via modulating IRE1/ATF6/RACK1/PERK and PGC-1α in diabetes mellitus" [Biomed. Pharmacother. 118 (2019) 109407]. | Biomed Pharmacother | 2024 | 39500697 | PubTator, text mining | PubMed |
| N-acetyltransferase 10 is implicated in the pathogenesis of cycling T cell-mediated autoimmune and inflammatory disorders in mice. | Nat Commun | 2024 | 39477944 | PubTator, text mining | PubMed |
| An Antagonist Antibody That Inhibits Cancer Cell Growth In Vitro through RACK1. | Pharmaceuticals (Basel) | 2024 | 39458945 | PubTator, text mining | PubMed |
| Ribosome Structural Changes Dynamically Affect Ribosome Function. | Int J Mol Sci | 2024 | 39456968 | PubTator, text mining | PubMed |
| Mtb/HIV co-infection immune microenvironment subpopulations heterogeneity. | Int Immunopharmacol | 2024 | 39405943 | PubTator, text mining | PubMed |
| Interrogating data-independent acquisition LC-MS/MS for affinity proteomics. | J Proteins Proteom | 2024 | 39372605 | PubTator, text mining | PubMed |
| RACK1 inhibits ferroptosis of cervical cancer by enhancing SLC7A11 core-fucosylation. | Glycoconj J | 2024 | 39356381 | PubTator, text mining | PubMed |
| Rack1 regulates B-cell development and function by binding to and stabilizing the transcription factor Pax5. | Cell Mol Immunol | 2024 | 39256480 | PubTator, text mining | PubMed |
| RACK1 links phyB and BES1 to coordinate brassinosteroid-dependent root meristem development. | New Phytol | 2024 | 39149918 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10399/papers?page=6